Other

Tax expense (benefit) of other comprehensive income (loss), reclassification adjustment from AOCI for sale of securities

Humana Tax expense (benefit) of other comprehensive income (loss), reclassification adjustment from AOCI for sale of securities decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $1.00M to $0.00.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2015
Last reportedQ1 2026Apr 29, 2026
Metric ID: other_other_comprehensive_income_loss_reclassification_a_2c7695

Historical Data

12 periods
 Q3 '21Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$4.00M-$11.00M-$15.00M$1.00M$0.00$0.00$0.00$2.00M$1.00M$0.00$11.00M$0.00
QoQ Change—-375.0%-36.4%+106.7%-100.0%———-50.0%-100.0%—-100.0%
YoY Change—-375.0%——+100.0%+100.0%-100.0%———+450.0%-100.0%
Range-$15.00M – $11.00M
CAGR-100.0%
Avg YoY Growth+12.5%
Median YoY Growth+0.0%

Frequently Asked Questions

What is Humana's tax expense (benefit) of other comprehensive income (loss), reclassification adjustment from aoci for sale of securities?
Humana (HUM) reported tax expense (benefit) of other comprehensive income (loss), reclassification adjustment from aoci for sale of securities of $0.00 in Q1 2026.
How has Humana's tax expense (benefit) of other comprehensive income (loss), reclassification adjustment from aoci for sale of securities changed year-over-year?
Humana's tax expense (benefit) of other comprehensive income (loss), reclassification adjustment from aoci for sale of securities decreased by 100.0% year-over-year, from $1.00M to $0.00.